A new study shows that an implantable delivery system for a widely used medication to treat a blinding eye disease has enabled some patients to go 15 months in between treatments. This represents a vast improvement over the typical regimen of nearly monthly eye injections.
from Top Health News -- ScienceDaily https://ift.tt/2JjRiJp
via IFTTT
No comments:
Post a Comment